Recent Finacing
Recent Raise
Newleos Therapeutics is a clinical-stage neuroscience company developing orally bioavailable small molecules—licensed from Roche—targeting GABAA-γ1, V1a, TAAR1 and GABAA-α5 across anxiety, substance use, and cognitive indications.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
